Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 04 2021 - 4:05PM
Business Wire
Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools
company commercializing a unique protein sequencing platform, today
announced that it will participate in the 2021 Canaccord Genuity
Virtual MedTech, Diagnostics and Digital Health & Services
Forum. John Stark, Chief Executive Officer, and Claudia Drayton,
Chief Financial Officer, will participate in a virtual fireside
chat on Thursday, November 18, 2021 at 2:30 p.m. ET.
A webcast of the event will be available on the Investors
section of Quantum-Si’s website under Events & Presentations. A
replay will be available on the Company’s website after the
event.
About Quantum-Si
Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused
on revolutionizing the growing field of proteomics. The Company's
suite of technologies is powered by a first-of-its-kind
semiconductor chip designed to enable single-molecule
next-generation protein sequencing, and digitize proteomic research
in order to advance drug discovery and diagnostics beyond what has
been possible with DNA sequencing.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211104006292/en/
Investor Contacts Juan Avendano VP of Investor Relations
(413) 537-8735 javendano@quantum-si.com Mike Cavanaugh ICR
Westwicke (617) 877-9641 ir@quantum-si.com Media Contact
Cammy Duong ICR Westwicke (203) 682-8380 QSI-PR@westwicke.com
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Jun 2024 to Jul 2024
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Jul 2023 to Jul 2024